HKG Equity Snapshot

2096 Weekly Equity Report

Simcere Pharmaceutical Group Limited

Interactive chart JSON snapshot
Latest Close 10.10 HKD 12 Jun 2026
1W Return 2.3% latest completed week
4W Return -11.2% short-term follow-through
12W Return -12.3% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. It develops Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; Leruiping, a fully human monoclonal antibody targeting IL-4Ra; Zemprocitinib a highly selective JAK1 inhibitor; and Xianlinda, an inhibitor for influenza polymerase acidic protein that has completed Phase 3 clinical trials. The company also develops SIM0270, a new-generation oral SERD with blood-brain barrier penetration characteristics; Denlorlatinib; SIM0395, a BBB-penetrant inhibitor of the PI3K/mTOR pathway; and …

Snapshot

What the weekly tape is saying

2096 closed the latest completed week at 10.10 HKD. The 4-week return is -11.2% and the 12-week return is -12.3%. Trend Signal is inactive, Market Dynamics is -1.04. Setup signature: Risk-first tape with a 17/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -16.8%
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 30 Persistence of active Trend Signal over the last year and current streak.
Momentum 13 Blend of 4-week and 12-week follow-through.
Dynamics 0 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 2 Relative leadership and short-term RS change.
Volume 51 Participation compared with the 13-week volume baseline.
Risk Control 5 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
12.13 HKD
Vs Trend Line
-16.8%
Fair Value
8.48 HKD
Vs Fair Value
19.0%
52W High
15.08 HKD
52W Low
9.46 HKD
Drawdown
-33.0%
Range Position
11.4%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W 2.3%
4W -11.2%
12W -12.3%
26W -22.8%
52W -16.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
28
52W Active Breadth
53.8%
Sector Scope
HK Healthcare
Sector Rank
52 of 257
Sector Percentile
80.1%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.04
4W MD Change
-1357.2%
Relative Strength
-14.69
4W RS Change
-48.5%
Expectation
Undecided
Probability
46.29%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
40.8M
13W Average
33.9M
52W Average
55.9M
Vs 13W
1.2x
Vs 52W
0.7x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
5.6%
52W Volatility
5.5%
Upside Weeks
24
Downside Weeks
27
Downside Breadth
51.9%
Avg Gain / Loss
4.3% / -4.2%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
HKD
Market Cap
25.9B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 10.10 HKD 2.3% 12.13 HKD 8.48 HKD -1.04 -14.69 40.8M Off
5 Jun 2026 9.87 HKD -1.0% 12.26 HKD 8.47 HKD -0.95 -17.77 34.4M Off
29 May 2026 9.97 HKD -4.3% 12.34 HKD 8.45 HKD -0.73 -18.06 28.0M Off
22 May 2026 10.42 HKD -8.4% 12.42 HKD 8.43 HKD -0.48 -16.27 37.3M Off
15 May 2026 11.38 HKD -4.8% 12.49 HKD 8.42 HKD -0.07 -9.89 31.2M Off
8 May 2026 11.96 HKD 1.0% 12.55 HKD 8.39 HKD 0.30 -6.59 20.7M Off
1 May 2026 11.84 HKD -6.2% 12.57 HKD 8.37 HKD 0.69 -5.04 14.1M Off
24 Apr 2026 12.62 HKD -8.5% 12.61 HKD 8.35 HKD 0.99 0.70 45.4M Off
17 Apr 2026 13.79 HKD 0.4% 12.61 HKD 8.32 HKD 0.67 9.72 34.9M Off
10 Apr 2026 13.74 HKD 0.9% 12.58 HKD 8.29 HKD 0.08 11.23 66.0M Off
3 Apr 2026 13.62 HKD 12.8% 12.58 HKD 8.26 HKD -0.60 14.35 38.1M Off
27 Mar 2026 12.07 HKD 4.8% 12.60 HKD 8.22 HKD -1.12 2.72 31.1M Off
20 Mar 2026 11.52 HKD -0.1% 12.67 HKD 8.19 HKD -1.12 -2.65 19.0M Off
13 Mar 2026 11.53 HKD -2.5% 12.76 HKD 8.17 HKD -1.04 -2.75 17.2M Off